About Mark Chin
Form D filings for Avenzoar Pharmaceuticals in 2023 list Mark Chin as director.
Mark Chin first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Chin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Chin works with at each company, as listed on that company's latest Form D.
Avenzoar Pharmaceuticals, Inc. · Form D, Jun 16, 2023
SW
Shierley Widjaja
Director
SP
Stephen Pandol
Director
ME
Mouad Edderkaoui
Director
TB
Terrance Bruggeman
Chief Executive Officer and director